Regarding mucins other than MUC1, pancreatic cancer cells become resistant to gemcitabine in parallel with MUC4 expression [4], and MUC13 overexpression in renal cell carcinoma was reported to play a central role in tumor progression and drug resistance [6]. This evidence concerns the gene MUC13 and pancreatic neoplasm.